Leerink Partners Upgrades Fulcrum Therapeutics (FULC) to Outperform
Tweet Send to a Friend
(Updated - May 23, 2025 6:21 AM EDT)
Leerink Partners analyst Joseph P. Schwartz upgraded Fulcrum Therapeutics (NASDAQ: FULC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Joseph P. Schwartz upgraded Fulcrum Therapeutics (NASDAQ: FULC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
